0001127602-19-021143.txt : 20190607
0001127602-19-021143.hdr.sgml : 20190607
20190607174153
ACCESSION NUMBER: 0001127602-19-021143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190606
FILED AS OF DATE: 20190607
DATE AS OF CHANGE: 20190607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KALKSTEIN MICHAEL
CENTRAL INDEX KEY: 0001183216
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08597
FILM NUMBER: 19887018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COOPER COMPANIES INC
CENTRAL INDEX KEY: 0000711404
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 942657368
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 6140 STONERIDGE MALL RD
STREET 2: STE 590
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: 9254603600
MAIL ADDRESS:
STREET 1: 6140 STONERIDGE MALL ROAD
STREET 2: SUITE 590
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: COOPERVISION INC
DATE OF NAME CHANGE: 19870701
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-06-06
0000711404
COOPER COMPANIES INC
COO
0001183216
KALKSTEIN MICHAEL
6140 STONERIDGE MALL DRIVE
SUITE 590
PLEASANTON
CA
94588
1
Common Stock
2019-06-06
4
M
0
3500
49.57
A
9838
I
The Kalkstein and English Family Trust u/a/d May 18, 2005
Common Stock
2019-06-06
4
S
0
3500
316.2813
D
6338
I
The Kalkstein and English Family Trust u/a/d May 18, 2005
Common Stock
0
D
Stock Options (Right to Buy)
49.57
2019-06-06
4
M
0
3500
0
D
2020-10-31
Common Stock
3500
3000
I
The Kalkstein and English Family Trust u/a/d May 18, 2005, as amended
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.2511 to $316.4611. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
All shares granted under this option are currently exercisable.
/s/ Michael H. Kalkstein
2019-06-07